癌症引起的心脏功能障碍:瘤心脏病学时代的机制,诊断和新兴治疗方法
Sarama Saha1, Praveen K Singh2, Partha Roy3
1Department of Biochemistry, All India Institute of Medical Sciences, Rishikesh 249203, India.
Cancers
|October 16, 2025
概括
癌症治疗可能会损害心脏,导致心脏毒性. 早期检测和个性化策略,包括Withaferin A等新药,对于在癌症患者中保持心脏健康至关重要.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 癌症引起的心脏功能障碍是越来越大的临床挑战,因为癌症存活率有所提高.
- 心脏毒性是癌症患者和癌症幸存者的疾病和死亡的主要原因.
- 病理生理学涉及炎症,氧化应激,神经激素失衡和代谢问题.
研究的目的:
- 审查癌症相关心脏毒性的机制.
- 讨论当前和新兴的治疗策略.
- 强调早期检测和个性化护理的必要性.
主要方法:
- 对心脏毒性机制和治疗方法的文献综述.
- 对与心脏并发症相关的瘤治疗方法的分析.
- 对药理和非药理干预措施的评估.
主要成果:
- 癌症和治疗 (人类环保素,特拉斯图祖马布,ICI) 可能导致心力衰竭和功能障碍.
- 多种机制有助于,包括炎症,氧化应激和神经激素因素.
- 药理学药物 (ACE抑制剂,β抑制剂,WFA) 和生活方式的改变显示出心脏保护的潜力.
结论:
- 多学科,个性化的方法对于管理癌症心脏毒性至关重要.
- 需要标准化的协议和长期数据.
- 合作是改善癌症存活率的关键,同时保持心血管健康.
相关概念视频
Cardiomyopathy I: Introduction and Classification
498
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
498
Cardiomyopathy II: Dilated Cardiomyopathy
464
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
464
Pathophysiology of Cardiac Performance
1.4K
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.4K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
399
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
399
Cardiomyopathy V: Interprofessional Care
335
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
335
Cardiomyopathy IV: Restrictive Cardiomyopathy
449
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
449


